Robert J. Spiegel - Net Worth and Insider Trading
Robert J. Spiegel Net Worth
The estimated net worth of Robert J. Spiegel is at least $424,917 dollars as of 2024-06-09. Robert J. Spiegel is the Director of Geron Corp and owns about 65,576 shares of Geron Corp (GERN) stock worth over $300,994. Robert J. Spiegel is the Chief Medical Officer of PTC Therapeutics Inc and owns about 3,239 shares of PTC Therapeutics Inc (PTCT) stock worth over $118,288. Robert J. Spiegel is also the Director of PDS Biotechnology Corp and owns about 1,933 shares of PDS Biotechnology Corp (PDSB) stock worth over $5,635. Details can be seen in Robert J. Spiegel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert J. Spiegel has not made any transactions after 2018-09-13 and currently still holds the listed stock(s).
Transaction Summary of Robert J. Spiegel
Robert J. Spiegel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert J. Spiegel owns 10 companies in total, including Geron Corp (GERN) , Athenex Inc (ATNXQ) , and Cyclacel Pharmaceuticals Inc (CYCC) among others .
Click here to see the complete history of Robert J. Spiegel’s form 4 insider trades.
Insider Ownership Summary of Robert J. Spiegel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GERN | Geron Corp | 2018-09-13 | director |
| ATNXQ | Athenex Inc | 2020-08-04 | director |
| CYCC | Cyclacel Pharmaceuticals Inc | 2020-06-25 | director |
 | | 2020-05-07 | director |
| | 2016-06-21 | director |
| | 2018-02-13 | director |
| | 2015-03-13 | Chief Medical Officer |
| | 2010-05-21 | director |
| | 2023-01-19 | director |
| | 2023-04-25 | director |
Robert J. Spiegel Latest Holdings Summary
Robert J. Spiegel currently owns a total of 3 stocks. Among these stocks, Robert J. Spiegel owns 65,576 shares of Geron Corp (GERN) as of September 13, 2018, with a value of $300,994 and a weighting of 70.84%. Robert J. Spiegel owns 3,239 shares of PTC Therapeutics Inc (PTCT) as of March 13, 2015, with a value of $118,288 and a weighting of 27.84%. Robert J. Spiegel also owns 1,933 shares of PDS Biotechnology Corp (PDSB) as of October 6, 2015, with a value of $5,635 and a weighting of 1.33%.
Latest Holdings of Robert J. Spiegel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GERN | Geron Corp | 2018-09-13 | 65,576 | 4.59 | 300,994 |
| PTCT | PTC Therapeutics Inc | 2015-03-13 | 3,239 | 36.52 | 118,288 |
| PDSB | PDS Biotechnology Corp | 2015-10-06 | 1,933 | 2.92 | 5,635 |
Holding Weightings of Robert J. Spiegel
Robert J. Spiegel Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert J. Spiegel has made a total of 0 transactions in Geron Corp (GERN) over the past 5 years. The most-recent trade in Geron Corp is the sale of 175,000 shares on September 13, 2018, which brought Robert J. Spiegel around $1 Million.
According to the SEC Form 4 filings, Robert J. Spiegel has made a total of 0 transactions in PTC Therapeutics Inc (PTCT) over the past 5 years. The most-recent trade in PTC Therapeutics Inc is the sale of 1,030 shares on March 13, 2015, which brought Robert J. Spiegel around $77,353.
According to the SEC Form 4 filings, Robert J. Spiegel has made a total of 0 transactions in PDS Biotechnology Corp (PDSB) over the past 5 years. The most-recent trade in PDS Biotechnology Corp is the acquisition of 150 shares on October 6, 2015, which cost Robert J. Spiegel around $33,000.
Insider Trading History of Robert J. Spiegel
- 1
Robert J. Spiegel Trading Performance
GuruFocus tracks the stock performance after each of Robert J. Spiegel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert J. Spiegel is -23.56%. GuruFocus also compares Robert J. Spiegel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert J. Spiegel within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert J. Spiegel's insider trading performs compared to the benchmark.
Performance of Robert J. Spiegel
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.44 | | | | | |
| Relative Return to S&P 500(%) | -12.46 | | | | | |
Robert J. Spiegel Ownership Network
Robert J. Spiegel Owned Company Details
What does Geron Corp do?
Who are the key executives at Geron Corp?
Robert J. Spiegel is the director of Geron Corp. Other key executives at Geron Corp include director & Chief Executive Officer John A Scarlett , EVP & Chief Financial Officer Michelle Robertson , and EVP & Chief Legal Officer Scott Alan Samuels .
Geron Corp (GERN) Insider Trades Summary
Over the past 18 months, Robert J. Spiegel made no insider transaction in Geron Corp (GERN). Other recent insider transactions involving Geron Corp (GERN) include a net sale of 1,940,000 shares made by John A Scarlett , a net sale of 400,000 shares made by Olivia Kyusuk Bloom , and a net sale of 384,719 shares made by Andrew J Grethlein .
In summary, during the past 3 months, insiders sold 600,000 shares of Geron Corp (GERN) in total and bought 0 shares, with a net sale of 600,000 shares. During the past 18 months, 2,794,719 shares of Geron Corp (GERN) were sold and 13,186 shares were bought by its insiders, resulting in a net sale of 2,781,533 shares.
Geron Corp (GERN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Geron Corp Insider Transactions
Robert J. Spiegel Mailing Address
Above is the net worth, insider trading, and ownership report for Robert J. Spiegel. You might contact Robert J. Spiegel via mailing address: C/o Geron Corporation, 230 Constitution Drive, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
